IV cyclophosphamide vs IV dexamethasone and oral cyclophosphamide
IV cyclophosphamide showed no clear difference in adverse events: bacterial infections compared with oral cyclophosphamide plus IV dexamethasone (low certainty).
- Interventions for idiopathic steroid‐resistant nephrotic syndrome in children 2019 · Cochrane Headline outcomes onlyRR 0.66 [0.27, 1.63]1 study · 49 participantsLow